Home > PS Ratio > AAREY DRUGS & PHARMACEUTICALS

AAREY DRUGS & PHARMACEUTICALS
PS (Price/Sales) Ratio

The Current P/S Ratio of AAREY DRUGS & PHARMACEUTICALS is 0.49.

Share Price ₹82.1Jul 14,2026
Market Cap ₹233.1 Cr
Sales-TTM₹472.3 CrTTM-Standalone Results
Price/Sales0.49xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for AAREY DRUGS & PHARMACEUTICALS
Please provide your vote to see the results
AAREY DRUGS & PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of AAREY DRUGS & PHARMACEUTICALS

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of AAREY DRUGS & PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹233.1 Cr] as on Jul 14,2026

(/) Sales [ ₹472.3 Cr] based on TTM-Standalone Results

(=) P/S Ratio [ 0.49x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for AAREY DRUGS & PHARMACEUTICALS , the investors are currently willing to pay '0.49 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of AAREY DRUGS & PHARMACEUTICALS !

The chart below summarizes the trend in P/S Ratio of AAREY DRUGS & PHARMACEUTICALS over the last five years.

Historical PS (Price/Sales) ratio chart of AAREY DRUGS & PHARMACEUTICALS


PS Ratio Performance Analysis for AAREY DRUGS & PHARMACEUTICALS

- AAREY DRUGS & PHARMACEUTICALS 's latest p/e ratio is 0.49x.

- AAREY DRUGS & PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 0.21x.

- AAREY DRUGS & PHARMACEUTICALS 's operated at median p/e ratio of 0.2x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, AAREY DRUGS & PHARMACEUTICALS 's p/e ratio peaked in Mar2024 at 0.32x.

- AAREY DRUGS & PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2023 of 0.14x.


How does AAREY DRUGS & PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Trading Industry?

Peer Comparison (Trading Industry)Sales (Cr)PS RatioMarket Cap (Cr)
AAREY DRUGS & PHARMACEUTICALS 472.30.49233.1
ADANI ENTERPRISES LTD100,469.04.30431,560.0
PREMIER ENERGIES LTD7,824.46.3849,939.2
ADITYA INFOTECH LTD4,220.810.1142,661.3
AEGIS LOGISTICS LTD8,333.25.1442,836.0
REDINGTON LTD119,162.00.1922,112.5
RRP SEMICONDUCTOR LTD-6.8-1,776.5712,118.0
HONASA CONSUMER LTD2,391.96.4715,486.2
LLOYDS ENTERPRISES LTD1,756.36.7611,868.9
MMTC LTD3.42,823.619,628.5
CELLO WORLD LTD2,323.73.478,070.0

Trading Industry Benchmark (Top 10) PS Analysis vs AAREY DRUGS & PHARMACEUTICALS 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS -1,776.57x
Max industry PS 2,823.61x
Median industry PS 5.14x
Average industry PS 99.12x



You may also like the below Video Courses